inhibit, Inhibitor, GSK2239633A, GSK-2239633A, CCR4, CC chemokine receptor, [125I]-TARC-CCR4, CCR
GSK2239633A is a potent allosteric antagonist of human CCR4, exhibiting a pIC50 of 7.96 in inhibiting [125I]-TARC binding. This small molecule is a valuable research tool for investigating CCR4 function in vitro and exploring its role in immunological and inflammatory disease models.
